Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages Stemming false Single Family Member true Include NPL false

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:C07D

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.WO/2021/203198COMPOSITIONS AND METHODS FOR TREATMENT OF CORONAVIRIDAE INFECTIONS
WO 14.10.2021
Int.Class A61K 38/50
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
43Enzymes; Proenzymes; Derivatives thereof
46Hydrolases (3)
50acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
Appl.No PCT/CA2021/050462 Applicant PICCHIO INTERNATIONAL INC. Inventor BELLINI, Francesco
The present technology generally relates to the use of an asparaginase compound, and optionally of a chloroquine active agent and/or a serine protease inhibitor and/or a lectin, for inhibiting or treating a Coronaviridae infection in a subject.
2.WO/2021/203768PYRIMIDO DICYCLO DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE
WO 14.10.2021
Int.Class C07D 491/056
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
491Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/-C07D459/290
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
056with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
Appl.No PCT/CN2021/000067 Applicant JIANGSU HENGRUI MEDICINE CO., LTD. Inventor LI, Xin
The present disclosure relates to a pyrimido dicyclo derivative, a preparation method therefor and the use thereof in medicine. In particular, the present disclosure relates to a pyrimido dicyclo derivative as shown in general formula (I), a preparation method therefor, a pharmaceutical composition containing the derivative and the use thereof as a therapeutic agent, especially the use thereof as SOS1 inhibitor and the use thereof in the preparation of a drug for treating conditions or disorders improved by inhibiting SOS1.
3.WO/2021/204188UTIDELONE SEMI-HYDRATED SINGLE CRYSTAL AND PREPARATION METHOD THEREFOR AND USE THEREOF
WO 14.10.2021
Int.Class A61K 31/427
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
425Thiazoles
427not condensed and containing further heterocyclic rings
Appl.No PCT/CN2021/085903 Applicant BEIJING BIOSTAR PHARMACEUTICALS CO., LTD. Inventor TANG, Li
A polycrystalline form of Utidelone, particularly relating to a semi-hydrated crystal form (A) of Utidelone, a preparation method therefor and a use of crystalline Utidelone in preparation of a pharmaceutical composition, especially the use in preparation of a pharmaceutical composition for inhibiting tumor growth and treating solid tumors of mammals, especially human. The provided crystal form is stable and resistant to high temperature and high humidity, and the preparation method is diversified and simple, and is suitable for industrialized production of new medicines.
4.WO/2021/204923PIPERAZINE DERIVATIVES AS ANTIVIRAL AGENTS FOR USE IN THE TREATMENT OF A CORONAVIRUS INFECTION
WO 14.10.2021
Int.Class A61K 31/496
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
Appl.No PCT/EP2021/059133 Applicant VIRONOVA MEDICAL AB Inventor KINGI, Ngarita
A compound of formula (I) for use in the treatment of a Coronaviridae virus infection. A novel compound of formula (I), and a process for preparing the compound.
5.WO/2021/205023PROCESS FOR THE PREPARATION OF SILODOSIN
WO 14.10.2021
Int.Class C07D 209/08
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
209Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
02condensed with one carbocyclic ring
04Indoles; Hydrogenated indoles
08with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
Appl.No PCT/EP2021/059344 Applicant MINAKEM Inventor BARAN, Phil
The present invention relates to a new process of preparation of Silodosin, or a pharmaceutically acceptable salt thereof. Another aspect of the invention concerns compounds of formula II: or their pharmaceutically acceptable salts thereof, and their use for the preparation of Silodosin or a pharmaceutically acceptable salt thereof.
6.WO/2021/205448CO-CRYSTALS OF ANTIOXIDANTS AND ACTIVE INGREDIENTS AND USE OF ANTIOXIDANTS AS STABILIZER
WO 14.10.2021
Int.Class C07D 498/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
498Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
Appl.No PCT/IL2021/050392 Applicant ADAMA AGAN LTD. Inventor GUBRIY, Vladimir
The present invention is directed to a co-crystal comprising a compound of formula (I) and an antioxidant, as well as to formulations comprising said co-crystals. The invention also discloses the use of an antioxidant to improve the stability of a compound of formula (I), stereoisomers, salts or solvates thereof, of a sulfonylurea, or of a mixture comprising both. The invention further discloses methods of storing, said compounds of formula (I) and to increase their shelf life.
7.WO/2021/207308CONDENSED PYRAZOLE DERIVATIVES AS INHIBITORS OF SARM1
WO 14.10.2021
Int.Class C07D 471/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
471Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/-C07D463/251
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
Appl.No PCT/US2021/026108 Applicant DISARM THERAPEUTICS, INC. Inventor BENTLEY, Jonathan
The present disclosure provides compounds of formula (I) and methods useful for inhibiting SARM1 and/or treating and/or preventing axonal degeneration.
8.20210317135RIP1K INHIBITORS
US 14.10.2021
Int.Class C07D 498/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
498Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
02in which the condensed system contains two hetero rings
04Ortho-condensed systems
Appl.No 17221493 Applicant Rigel Pharmaceuticals, Inc. Inventor Ihab Darwish

Disclosed herein are kinase inhibitory compounds, such as a receptor-interacting protein-1 (RIP1) kinase inhibitor compounds, as well as pharmaceutical compositions and combinations comprising such inhibitory compounds. The disclosed compounds, pharmaceutical compositions, and/or combinations may be used to treat or prevent a kinase-associated disease or condition, particularly a RIP1-associated disease or condition.

9.WO/2021/204159MENIN INHIBITORS AND METHODS OF USE FOR TREATING CANCER
WO 14.10.2021
Int.Class C07D 401/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
401Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
02containing two hetero rings
04directly linked by a ring-member-to-ring- member bond
Appl.No PCT/CN2021/085824 Applicant AGIOS PHARMACEUTICALS, INC. Inventor ZHOU, Shubao
The present disclosure provides compounds represented by Formula (I), or a pharmaceutically acceptable salt thereof, wherein Ra, Rb, Rc, Rd, V, Q, T, n, p, q, r and s are as defined as set forth in the specification. The present disclosure also provides compounds of Formula (I) for use to treat cancer or any other disease, condition, or disorder that is responsive to inhibition of menin.
10.WO/2021/204669SUBSTITUTED ISOPHTHALIC ACID DIAMIDES
WO 14.10.2021
Int.Class C07D 257/06
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
257Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
02not condensed with other rings
04Five-membered rings
06with nitrogen atoms directly attached to the ring carbon atom
Appl.No PCT/EP2021/058617 Applicant BAYER AKTIENGESELLSCHAFT Inventor WALDRAFF, Christian
The invention relates to substituted isophthalic acid diamides and to their use as herbicides. Disclosed are isophthalic acid diamides having general formula (I) as herbicides. In this formula (I), Z1 and Z2 represent radicals such as alkyl, cycloalkyl and phenyl. Q represents a heterocyclic ring such as tetrazolyl.